Followers | 62 |
Posts | 10254 |
Boards Moderated | 0 |
Alias Born | 06/03/2008 |
Friday, February 18, 2022 3:17:53 PM
Of course not PR'ed, since that would get too much visibility! Instead only filed as an 8K, because this is what you do when you are pink!
Item 8.01 Other Events.
On November 11,2021 Regen Biopharma, Inc. (the “Company”) entered into a Letter of Intent ( “LOI”) with Canary Oncoceutics, Inc (“Canary”) and Canary Oncoceutics Partners, LLC (“LLC”) whereby the Company would acquire 95% of the share capital and voting power of Canary ( “Canary Controlling Interest”) for consideration consisting of $1,000,000 and common shares of the Company valued at the average share price of the common shares in the 2 weeks prior to the closing of a definitive agreement between the parties (“RGBP Share Value”). The transaction contemplated by the LOI was contingent upon the execution of one or more mutually acceptable definitive agreements between the parties.
As of February 18, 2022 the Company has terminated all negotiations regarding the contemplated transaction.
https://ih.advfn.com/stock-market/USOTC/regen-biopharma-pk-RGBPP/stock-news/87334793/current-report-filing-8-k
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM